PipeLime: $3,930 MRR from AI sales agents, per payment data on TrustMRR
TrustMRR pulls this revenue from Stripe. PipeLime is an AI outbound sales platform with autonomous AI sales agents.
Subject: PipeLimeSubscription after a 14-day pilot
Case Overview & Background
PipeLime and is an AI outbound sales platform with autonomous AI sales agents. The listing gives a founding date of 2024-02-27. TrustMRR shows $3,604 in the last 30 days, $3,930 MRR, $101,830 all-time revenue, 10 active subscriptions as of November 2, 2026.
How AI Is Used
Step-by-Step Process
The business focuses on one outcome: an AI outbound sales platform with autonomous AI sales agents.
Pricing on the listing: No credit card · 14-day pilot.
Revenue is shared publicly through a Stripe connection on TrustMRR.
Customer Acquisition & Distribution
Limitations, Risks & Failure Modes
What may not apply to you, and what could go wrong:
- Revenue is not profit; AI model, hosting and marketing costs are not shown
- Figures change daily; this is a snapshot from November 2, 2026
- Products built on third-party AI models depend on those providers' pricing and policies
Key Takeaways
- A narrow AI product or service with a clear outcome can be sold directly to consumers or businesses
- Payment-provider-verified figures are stronger than screenshots but are still not an audit
Sources
TrustMRR verified revenue page: PipeLime
Note: Revenue pulled from Stripe. Viewed November 2, 2026. Product description on the page is written by the founder.
Category page banner: Reach readers researching one specific AI business model.
One clearly labelled banner on a category page such as Micro-SaaS or AI Agencies, shown next to the documented cases your product is relevant to.
Sponsored placements are always labelled and never change how cases are researched, labelled, or ranked.
Commercial disclosure: We currently have no affiliate or sponsorship relationship with any tool or person on this page. If that changes, affiliate links and sponsored content will be clearly labelled, and evidence labels will never be changed for commercial reasons.
